Business Standard

Retail investors see opportunity in the rising market

Redeem over Rs 3,000 crore from equity schemes in January

Related News

A 15 per cent spike in the since the beginning of the year has given retail investors an opportunity to exit their (MF) schemes. The net outflows from MFs were Rs 456 crore in January, according to statistics from the Association of Mutual Funds in India (AMFI).

However, the actual sale figures were much higher. The industry witnessed inflows of Rs 2,700 crore, whereas redemptions were to the tune of Rs 3,200 crore, leading to net outflows of Rs 456 crore.

Fund managers said that many investors who were stuck since 2009-10 due to the continuous decline in the markets chose to sell their units in the recent rally. The outflows last month were the highest since July, when investors had sold to the tune of Rs 729 crore. Even sales of continued to be slow during the month.

Net inflows/outflows 
Categories of schemes Net onflows/(Outflows)
Income -2,926
Equity -456
Balanced -101
Liquid/Money Market 26,429
Gilt 521
ElSS 76
Gold ETFs 82
Other ETFs -11
Fund of Funds 
Investing Overseas

All figures in Rs Crore

Trend of equity flows so far in FY12

Net Inflows/(Outflows)

April -1,076
May 1,546
June 20
July -729
August 1,942
September 1,401
October 181
November -49
December 360
January -456
Source : Amfi

Rajiv Anand, chief executive officer (CEO), Axis Mutual Fund, says, “Inflows in the equity segment have largely been not strong. Redemptions were more than inflows. In other words, the number of new investors was lesser than those who moved out.”

Fund managers said the large redemption pressure came only in the last few days of the month as investors moved to tax-free bonds of NHAI, PFC, Hudco and IRFC.

Investors had been stuck for two years. “They preferred to book marginal gains or losses in their mutual fund investments and shift to such bonds,” says Gupta.

This holds true for investors in of equity-diversified funds. For instance, till December an equity folio with investment of Rs 2,000 per month over the last one-and-a-half-years was 10 per cent lower than the investments. But the steep bull run in January brought the fund value at par with the costs.

The Bombay Stock Exchange Sensitive Index, or Sensex, after touching its peak in November, 2010, lost a fourth of its value in 2011. Investors, even those with systematic investment plans (SIPs), made losses during this period.

“So, the January rally provided an opportunity for investors to quit,” explains Akshay Gupta, CEO of Peerless Mutual Fund. It was a rare occasion to see such a sharp rally in indices and the selling which followed was more of an opportunistic call by investors, he adds.

Of the total industry assets, equity is 22 per cent at around Rs 1.6 lakh crore. This category is mainly dominated by retail and high net worth individuals.

According to MF tracking agency Value Research, so far this year the equity-oriented schemes have outperformed other asset classes.

Schemes in the categories of banking, infrastructure, and tax planning have been among the top performing schemes of the industry in the last one month.

Read more on:   

Read More

Budget 2013: Market reactions

The Union Budget was broadly along expected lines, given the constraints, and the government continued to focus on inclusive growth

Quick Links

Market News

Markets rise on ECB tide

World markets rallied on Friday after the European Central Bank decided on Thursday to pump a little over about euro 1 trillion to revive the ...

ECB's QE unlikely to result in widespread gains for all asset classes

Cheap money to seek high-yielding assets; prices of others like industrial metals, gold could settle

Sensex records sharpest seven-day rally since 2009

The Sensex surged 273 points on Friday to close at 29,278.84, and has rallied 1,932 points in the past seven trading days since January 15

Gold imports came to halt as discounts widened

High discounts are due to huge carry over stock of gold imported in November

GSK Pharma, select MNC stocks gain as Sebi eases delisting norm

In intra-day trade, GSK Pharma gained as much as 12% and ended 6.4% higher at Rs 3,347.45


Back to Top